Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

NEUROMETRIX, INC.

(NURO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about NEUROMETRIX, INC.
10/21NeuroMetrix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended ..
CI
10/21NEUROMETRIX : Reports Q3 2021 Financial Results - Form 8-K
PU
10/21NEUROMETRIX : Earnings Flash (NURO) NEUROMETRIX Reports Q3 Revenue $2.1M
MT
10/21NeuroMetrix Reports Q3 2021 Financial Results
GL
10/20NeuroMetrix, Inc. Names Susan M. Bell, RN, BN, as Senior Vice President of Population H..
CI
10/14NeuroMetrix, Inc. Announces Date for Third Quarter 2021 Financial Results Conference Ca..
GL
10/07NeuroMetrix Shares Rise 10% After Submitting De Novo Request for Quell
DJ
10/07NEUROMETRIX : Announces Submission of FDA De Novo Request for Treatment of Fibromyalgia Sy..
AQ
10/07NEUROMETRIX : Files for FDA De Novo Clearance for Quell Device to Treat Symptoms of Fibrom..
MT
10/06NeuroMetrix Announces Submission of FDA De Novo Request for Treatment of Fibromyalgia S..
GL
10/06NeuroMetrix Announces Submission of U.S. Food and Drug Administration De Novo Request f..
CI
10/05NEUROMETRIX : Announces Participation in the Center to Stream Healthcare In Place (C2SHIP)..
AQ
08/27Top Premarket Gainers
MT
08/13INSIDER TRENDS : Insider Sale at NeuroMetrix Scaling Back 90-Days of Buying
MT
08/13NEUROMETRIX : Consent of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. (included in ..
PU
07/26NEUROMETRIX : Announces Peer-Reviewed Publication of a Randomized Controlled Trial of its ..
AQ
07/22NEUROMETRIX : Q2 Loss Narrows as Revenue Climbs
MT
07/22Wall Street Wavers Pre-Bell as Jobless Claims Rise
MT
07/22Top Pre-Market Gainers
MT
07/22NEUROMETRIX : Reports Q2 2021 Financial Results (Form 8-K)
PU
07/22NEUROMETRIX : Earnings Flash (NURO) NEUROMETRIX Reports Q2 Revenue $2.2M
MT
07/22NEUROMETRIX : Reports Q2 2021 Financial Results
AQ
07/22NeuroMetrix, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quar..
CI
07/21NeuroMetrix Shares Continue to Rise on Tuesday's Breakthrough Designation for Quell
DJ
07/21NEUROMETRIX : Continues to Soar on FDA's Breakthrough Designation for Quell; Shares Surge ..
MT
07/20SECTOR UPDATE : Health Care Stock Drifting Away From Earlier Highs This Afternoon
MT
07/20UPDATE : NeuroMetrix Jumps 200% After Nerve-Stimulation Device Wins FDA Breakthrough Desig..
MT
07/20NeuroMetrix Shares Rocket 222% as Device Gets Breakthrough Designation From FDA
DJ
07/20SECTOR UPDATE : Health Care Stocks Posting Solid Afternoon Gains
MT
07/20NEUROMETRIX : Soaring After Its Nerve-Stimulation Device Wins FDA Breakthrough Designation..
MT
07/20NeuroMetrix Receives FDA Breakthrough Device Designation for Treatment of Fibromyalgia ..
GL
07/15NEUROMETRIX : Announces Date for Second Quarter 2021 Financial Results Conference Call
AQ
06/30NeuroMetrix, Inc. Enter into a Termination of Development and Services Agreement with G..
CI
06/15NeuroMetrix Reports that Quell« Technology is to be Evaluated for Neuromyelitis Optica ..
GL
06/15NeuroMetrix, Inc. Announces Quell Technology
CI
06/11NEUROMETRIX : THIRD AMENDED AND RESTATED BY-LAWS OF (Form 8-K)
PU
06/09NeuroMetrix Announces That Top-Line Results from a Randomized Controlled Trial of Quell..
GL
06/09NeuroMetrix Announces Top-Line Results from a Randomized Controlled Trial of Quell for ..
CI
04/22NeuroMetrix Reports Q1 2021 Financial Results
GL
04/22Neurometrix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
04/15NeuroMetrix, Inc. Announces Date for First Quarter 2021 Financial Results Conference Ca..
GL
01/28Neurometrix, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 20..
CI
01/28NEUROMETRIX : Earnings Flash (NURO) NEUROMETRIX Reports Q4 Revenue $1.8M
MT
01/28NeuroMetrix Reports Q4 and Full Year 2020 Financial Results
GL
01/25NEUROMETRIX : Announces Date for Fourth Quarter and Full Year 2020 Financial Results Confe..
AQ
01/22NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2020 Financial Result..
GL
2020NEUROMETRIX : Reports Q3 2020 Financial Results
AQ
2020Neurometrix, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 20..
CI
2020NEUROMETRIX : Reports Q3 2020 Financial Results
AQ
2020NeuroMetrix Reports Q3 2020 Financial Results
GL
2020NEUROMETRIX : Announces Date for Third Quarter 2020 Financial Results Conference Call
AQ
2020NEUROMETRIX : Announces Date for Third Quarter 2020 Financial Results Conference Call
AQ
2020NeuroMetrix, Inc. Announces Date for Third Quarter 2020 Financial Results Conference Ca..
GL
2020NEUROMETRIX : Launches Quell App for Apple Watch, the First Smartwatch App for an Over-the..
AQ
2020NEUROMETRIX : Launches Quell« App for Apple Watch«, the First Smartwatch App for an Over-t..
AQ
2020NeuroMetrix Launches Quell« App for Apple Watch«, the First Smartwatch App for an Over-..
GL
2020NeuroMetrix, Inc. Launches Quell« App for Apple Watch«, the First Smartwatch App for an..
CI
2020NEUROMETRIX : Announces Issuance of New U.S. Patent for Quell« Wearable Technology
AQ
2020NeuroMetrix Announces Issuance of New U.S. Patent for Quell« Wearable Technology
GL
2020NeuroMetrix Reports Scientific Presentation at the PAINWeek 2020 Live Virtual Conferenc..
GL
2020NEUROMETRIX : Reports Publication of Study Validating DPNCheck Staging of Diabetic Periphe..
AQ
2020NeuroMetrix Reports Publication of Study Validating DPNCheck« Staging of Diabetic Perip..
GL
2020NeuroMetrix Reports Publication of Study Validating DPNCheck« Staging of Diabetic Perip..
CI
2020NEUROMETRIX : Reports that Quell is to be evaluated for Chemotherapy-Induced Peripheral Ne..
AQ
2020NeuroMetrix Reports that Quell« is to be Evaluated for Chemotherapy-Induced Peripheral ..
GL
2020NeuroMetrix Reports that Quell« is to be Evaluated for Chemotherapy-Induced Peripheral ..
CI
2020NEUROMETRIX : Quell Fills Unmet Need for Chronic Knee Pain Relief that is Drug-Free
AQ
2020Quell« Fills Unmet Need for Chronic Knee Pain Relief that is Drug-Free
GL
2020NeuroMetrix, Inc. Quell Fills Unmet Need for Chronic Knee Pain Relief That Is Drug-Free
CI
2020NeuroMetrix Reports Q2 2020 Financial Results
GL
2020Neurometrix, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020
CI
2020NeuroMetrix, Inc. Announces Date for Second Quarter 2020 Financial Results Conference C..
GL
2020NEUROMETRIX : Reports DPNCheck Expansion in China
AQ
2020NeuroMetrix Reports DPNCheck« Expansion in China
GL
2020NeuroMetrix, Inc. Reports DPNCheck« Expansion in China
CI
1  2  3Next
Upcoming event on NEUROMETRIX, INC.
01/27/22